| Financial Year |
March 31 2023 |
| Monetary Funds |
4,606,259,274.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
967,737,627.47 |
| Advances to Suppliers |
280,125,235.56 |
| Other Receivables |
19,745,216.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,340,898,666.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
211,435,533.74 |
| Total Current Assets |
9,612,268,822.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
204,963,169.45 |
| Investment Properties |
-- |
| Fixed Assetes |
7,372,615,886.71 |
| Under-construction Projects |
2,141,811,108.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,135,486,981.23 |
| R&D expenses |
51,119,003.93 |
| Goodwill |
1,838,405,543.83 |
| Long-Term Deferred and Prepaid Expenses |
5,766,597.50 |
| Deferred Income Tax Assets |
42,417,653.61 |
| Other Non-Current Assets |
129,020,017.54 |
| Sub-Total of Non-Current Assets |
14,425,241,245.83 |
| Total Assets |
24,037,510,067.91 |
| Short-Term Loans |
1,071,576,778.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
230,691,730.88 |
| Accounts Payable |
1,568,688,410.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,381,763.79 |
| Taxes Payable |
73,869,325.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,503,024.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
354,151,062.71 |
| Other Current Liabilities |
9,414,203.56 |
| Sub-Total of Current Liabilities |
3,465,833,431.79 |
| Long-term Loans |
200,223,055.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
103,276,543.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
401,834,679.75 |
| Total Liabilities |
3,867,668,111.54 |
| Paid-In Capital(Or Share Stock) |
8,831,250,228.00 |
| Capital Surplus |
1,124,527,583.61 |
| Surplus Reserve |
488,124,338.77 |
| LESS:Treasury Stock |
150,000,004.48 |
| Undistributed Profits |
9,221,354,794.60 |
| Minority Stockholder's Interest |
628,269,404.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,541,572,552.22 |
| Owner's Equity（Stockholder's Equity） |
20,169,841,956.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,037,510,067.91 |
